These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 830220)
21. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Bergmann SR; Lerch RA; Fox KA; Ludbrook PA; Welch MJ; Ter-Pogossian MM; Sobel BE Am J Med; 1982 Oct; 73(4):573-81. PubMed ID: 6981998 [TBL] [Abstract][Full Text] [Related]
22. Localization of viable, ischemic myocardium by positron-emission tomography with 11C-palmitate. Lerch RA; Ambos HD; Bergmann SR; Welch MJ; Ter-Pogossian MM; Sobel BE Circulation; 1981 Oct; 64(4):689-99. PubMed ID: 6974061 [No Abstract] [Full Text] [Related]
23. Enhancement of metabolism of jeopardized myocardium by nifedipine. Jaffe AS; Biello DR; Sobel BE; Geltman EM Int J Cardiol; 1987 Apr; 15(1):77-89. PubMed ID: 3553039 [TBL] [Abstract][Full Text] [Related]
24. Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. Maroko PR; Libby P; Ginks WR; Bloor CM; Shell WE; Sobel BE; Ross J J Clin Invest; 1972 Oct; 51(10):2710-6. PubMed ID: 5056663 [TBL] [Abstract][Full Text] [Related]
26. Myocardial infarction size from serial CPK: variability of CPK serum entry ratio with size and model of infarction. Cairns JA; Missirlis E; Fallen EL Circulation; 1978 Dec; 58(6):1143-53. PubMed ID: 709770 [TBL] [Abstract][Full Text] [Related]
27. Cardiac positron tomography: current status and future directions. Geltman EM; Roberts R; Sobel BE Herz; 1980 Apr; 5(2):107-19. PubMed ID: 6970158 [TBL] [Abstract][Full Text] [Related]
28. Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography. Vanoverschelde JL; Wijns W; Kolanowski J; Bol A; Decoster PM; Michel C; Cogneau M; Heyndrickx GR; Essamri B; Melin JA Am J Physiol; 1993 Mar; 264(3 Pt 2):H701-7. PubMed ID: 8456973 [TBL] [Abstract][Full Text] [Related]
29. Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog. Vogel WM; Zannoni VG; Abrams GD; Lucchesi BR Circulation; 1977 Apr; 55(4):588-95. PubMed ID: 837501 [TBL] [Abstract][Full Text] [Related]